| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.36B | 2.33B | 2.32B | 2.38B | 2.42B | 1.79B |
| Gross Profit | 1.11B | 1.10B | 1.10B | 1.14B | 1.18B | 804.47M |
| EBITDA | 41.11M | 66.72M | 35.84M | 136.66M | 190.36M | -59.66M |
| Net Income | -24.25M | -18.89M | -16.83M | 71.92M | 114.85M | -56.03M |
Balance Sheet | ||||||
| Total Assets | 1.42B | 1.34B | 1.33B | 1.46B | 1.56B | 1.59B |
| Cash, Cash Equivalents and Short-Term Investments | 40.99M | 34.01M | 35.16M | 47.99M | 320.52M | 215.09M |
| Total Debt | 452.86M | 485.09M | 522.94M | 580.43M | 632.64M | 734.04M |
| Total Liabilities | 867.22M | 788.57M | 758.69M | 849.46M | 959.63M | 1.02B |
| Stockholders Equity | 554.71M | 546.97M | 571.20M | 606.97M | 602.47M | 566.76M |
Cash Flow | ||||||
| Free Cash Flow | 18.78M | 46.75M | 34.49M | -224.82M | 185.97M | 133.61M |
| Operating Cash Flow | 79.22M | 87.89M | 94.80M | -164.88M | 239.87M | 157.74M |
| Investing Cash Flow | -60.44M | -41.13M | -60.00M | -59.93M | -33.90M | -24.02M |
| Financing Cash Flow | -23.04M | -47.00M | -47.58M | -45.53M | -101.17M | -3.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $501.74M | 8.07 | 9.69% | 3.23% | -6.42% | -19.27% | |
| ― | $371.37M | ― | 0.19% | ― | 1.64% | ― | |
| ― | $229.48M | 6.31 | 34.74% | 2.06% | -2.37% | -16.40% | |
| ― | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
| ― | $313.18M | ― | -4.81% | ― | 2.66% | -4772.54% | |
| ― | $158.94M | -8.24 | ― | ― | -12.08% | 93.16% | |
| ― | $123.96M | 40.06 | ― | ― | -5.76% | -75.71% |
Genesco’s recent earnings call painted a picture of robust growth tempered by regional challenges. The company reported strong comparable sales growth, particularly in the Journeys segment, and positive developments in store channel performance and Johnston & Murphy’s turnaround. However, challenges in the U.K. market affecting Schuh and the impact of tariffs on the Genesco Brands Group were noted. Despite these hurdles, the company maintains an optimistic outlook for the future.
Genesco Inc. is a Nashville-based footwear company known for its diverse retail and lifestyle brands, including Journeys, Schuh, and Johnston & Murphy, with a strong presence in the U.S., Canada, and the U.K. In its fiscal 2026 second quarter report, Genesco Inc. announced a 4% increase in net sales, reaching $546 million, and a notable 9% rise in Journeys’ comparable sales, marking the fourth consecutive quarter of positive growth. Despite a GAAP EPS loss of $1.79, the company raised its full-year sales outlook, driven by strong performance in key segments.
Genesco Inc. reported its fiscal 2026 second-quarter results, showing a 4% increase in net sales to $546 million compared to the previous year. The company experienced a 4% rise in comparable sales, driven by a 9% increase at Journeys. Despite a GAAP operating loss of $14.4 million, Genesco raised its full-year sales outlook, reflecting confidence in its strategic growth initiatives. The company continues to navigate challenges such as tariffs and a competitive market environment, while focusing on product elevation and customer experience to maintain momentum.
The most recent analyst rating on (GCO) stock is a Hold with a $34.00 price target. To see the full list of analyst forecasts on Genesco stock, see the GCO Stock Forecast page.